Contrave-induced weight loss is known to play a role in reducing high cholesterol levels. Studies found that patients taking this drug had better lipid profiles:
In obese patients, the naltrexone/bupropion combination significantly reduced the levels of low-density lipoprotein (bad cholesterol) and increased the levels of high-density lipoprotein (good cholesterol).